Volume: 44 Suppl: 2
- September 2016
Show Abstracts
|
<< Back
INVITED REVIEW
1.
Clinical pharmacology of the apixaban and frequently asked questions about its clinical use
Adnan Abacı
Pages 1 - 6
Abstract
|
Full Text PDF
(Article in Turkish)
2.
Protection in atrial fibrillation
Lale Tokgözoğlu
, Bülent Görenek
Pages 7 - 13
Abstract
|
Full Text PDF
(Article in Turkish)
3.
ARISTOTLE study and sub-group analyses: Conspicuous points
Özgür Aslan
Pages 14 - 25
Abstract
|
Full Text PDF
(Article in Turkish)
4.
The use of new oral anticoagulants in atrial fibrillation patients unsuitable for warfarin therapy
Mesut Demir
Pages 26 - 32
Abstract
|
Full Text PDF
(Article in Turkish)
5.
Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?
Necla Özer
Pages 33 - 40
Abstract
|
Full Text PDF
(Article in Turkish)
6.
Venous thromboembolism studies of apixaban and its clinical use
A. Kürşat Bozkurt
Pages 41 - 46
Abstract
|
Full Text PDF
(Article in Turkish)